<DOC>
	<DOCNO>NCT00843791</DOCNO>
	<brief_summary>The purpose study learn insulin resistance ( inability process glucose correctly result mildly elevate glucose level ) affect hormone ghrelin .</brief_summary>
	<brief_title>Ghrelin Regulation Structure : Effect Thiazolidinedione Therapy Ghrelin</brief_title>
	<detailed_description>Insulin resistance suppresses fast ghrelin level impair postprandial ghrelin suppression . Improved insulin sensitivity thiazolidinedione raise ghrelin level , enhance meal-related suppression , change ratio total active ghrelin result alteration ghrelin structure .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>2,4-thiazolidinedione</mesh_term>
	<criteria>Age 18 80 , weight stable least 3 month At lifetime maximal body weight impaired glucose tolerance ( ICT ) World Health ORganization criterion : fasting plasma glucose level 100 125mg/dL plasma glucose level 140 149mg/dL follow 75gram oral glucose load Actively lose weight Smokers Alcohol consumption &gt; 2 drinks/day Prescription drug use Recreational drug use Type 2 Diabetes Conditions contraindicate treatment pioglitazone CHF , impair liver kidney function know sensitivity pioglitazone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>obesity</keyword>
</DOC>